<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02564731</url>
  </required_header>
  <id_info>
    <org_study_id>BCHlung003</org_study_id>
    <nct_id>NCT02564731</nct_id>
  </id_info>
  <brief_title>Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study</brief_title>
  <official_title>Prognosis of Bronchiectasis in Children--A Multicenter Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baoping XU</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wuhan women and children's health care center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yuying Children's Hospital of Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Changchun</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangxi Province Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Guangxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Xiamen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital Of Guizhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanxi Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective cohort study is designed to observe of the effect of intervention therapy on
      the long-term prognosis of children with bronchiectasis. The main purpose of the study was to
      evaluate the degree of deterioration of lung function, to observe and compare the quality of
      life, the time of pulmonary exacerbation, and the changes of lung image.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All enrolled patients are followed up for half a year, 1 years, 2 years, 3 years, 4 years, 5
      years, while observation of pulmonary function, symptoms, signs, quality of life, the times
      of acute pulmonary exacerbation, and the changes of lung image are performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in lung function on the spirometry</measure>
    <time_frame>5 years</time_frame>
    <description>forced expiratory volume at one second (FEV1) in Liter</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Bronchiectasis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children who was confirmed diagnosis as bronchiectasis at the certain hospitals (sponsor
        and collaborators)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:A included patient must be coincident at least one point of the four
        items of high-resolution computed tomography (HRCT) manifestations.

          -  Internal bronchial diameter greater than the accompanying pulmonary artery.

          -  lack of bronchial tapering

          -  bronchi visible in the peripheral 1cm of lung

          -  bronchial diameter greater than adjacent segmental bronchi

        Exclusion Criteria:Subject will be excluded if she or he has one of the following

          -  It is unable or doesn't agree to accept the follow-up process

          -  undergoing trial for other medications or instruments.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kunling Shen, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Children's Hospital of Capital Medical University, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Baoping Xu, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Children's Hospital of Capital Medical University, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaoxia Peng, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Children's Hospital of Capital Medical University, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Baoping Xu, MD,PhD</last_name>
    <phone>861059616308</phone>
    <email>xubaopingbch@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Children'S Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100045</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>baoping xu</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Karakoc GB, Yilmaz M, Altintas DU, Kendirli SG. Bronchiectasis: still a problem. Pediatr Pulmonol. 2001 Aug;32(2):175-8.</citation>
    <PMID>11477735</PMID>
  </reference>
  <reference>
    <citation>Munro KA, Reed PW, Joyce H, Perry D, Twiss J, Byrnes CA, Edwards EA. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr Pulmonol. 2011 Feb;46(2):131-8. doi: 10.1002/ppul.21331. Epub 2010 Aug 17.</citation>
    <PMID>20717910</PMID>
  </reference>
  <reference>
    <citation>Twiss J, Stewart AW, Byrnes CA. Longitudinal pulmonary function of childhood bronchiectasis and comparison with cystic fibrosis. Thorax. 2006 May;61(5):414-8. Epub 2006 Feb 7.</citation>
    <PMID>16467074</PMID>
  </reference>
  <reference>
    <citation>Murray MP, Pentland JL, Hill AT. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009 Nov;34(5):1086-92. doi: 10.1183/09031936.00055509. Epub 2009 Jun 18.</citation>
    <PMID>19541717</PMID>
  </reference>
  <reference>
    <citation>Davies G, Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin. Thorax. 2004 Jun;59(6):540-1.</citation>
    <PMID>15170047</PMID>
  </reference>
  <reference>
    <citation>Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2013 Oct;1(8):610-620. doi: 10.1016/S2213-2600(13)70185-1. Epub 2013 Sep 17. Erratum in: Lancet Respir Med. 2015 Aug;3(8):e29.</citation>
    <PMID>24461664</PMID>
  </reference>
  <reference>
    <citation>Gaylor AS, Reilly JC. Therapy with macrolides in patients with cystic fibrosis. Pharmacotherapy. 2002 Feb;22(2):227-39. Review.</citation>
    <PMID>11837560</PMID>
  </reference>
  <reference>
    <citation>WANG Hao，XU Bao-ping，LIU Xiu-yun，HU Ying-hui，REN Yi-xin，SHEN Kun-ling. Clinical characteristics and follow-up of bronchiectasis in children. Chinese Journal of Practical Pediatrics, 2014;29 (12):936-939</citation>
  </reference>
  <reference>
    <citation>CHEN Jun, DUO Li-kun, WANG Xiao-feng. Clinical analysis of 22 children with bronchiectasis. J Clin Pediatr, 2012, 30(1):51-54.</citation>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2015</study_first_submitted>
  <study_first_submitted_qc>September 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2015</study_first_posted>
  <last_update_submitted>January 5, 2017</last_update_submitted>
  <last_update_submitted_qc>January 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Children's Hospital</investigator_affiliation>
    <investigator_full_name>Baoping XU</investigator_full_name>
    <investigator_title>Chief of Respiratory Department</investigator_title>
  </responsible_party>
  <keyword>children</keyword>
  <keyword>prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

